The authorisation holder has an organisation enabling it to record in writing, in order to ensure traceability, referrals of patients for the continuation of systemic cancer drug treatments close to their home within the framework of an association mentioned in Article R. 6123-90-1 and any initial prescriptions for significant changes in treatment made within this framework by advanced consultations or teleconsultations in application of the last paragraph of Article R. 6123-94 and in compliance with the provisions of 1° of Article R. 6123-91-1.